Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril arginine + amlodipine versus valsartan + amlodipine in mild to moderate essential hypertension
2010-020945-28Phase 3Completed
- Sponsor
- Servier
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in essential hypertension comparing Perindopril arginine + amlodipine strategy with Valsartan + amlodipine strategy (2 arms). Primary endpoint: Change in office systolic blood pressure at month 3. Started Sep 2010; status: completed.
02
Drugs
perindoprilamlodipinevalsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2010-020945-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020945-28.